Inquiry Basket
| Description: | ((1-Chloro-2-methylpropan-2-yl)oxy)trimethylsilane is an intermediate for the synthesis of 3-Hydroxy Bortezomib (H818150), which is a metabolite of Bortezomib (B675700); the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. |
| Molecular Weight: | 180.75 |
| Molecular Formula: | C7H17ClOSi |
| Solubility: | Dichloromethane; Ethyl Ether |
| Appearance: | Clear Colorless Oil |
| References: | Nawrocki, S.T., et al. Cancer Res., 65, 11510 (2005); Drahl, C. Chem. and Eng. News, 87, 41 (2009). |
Catalog: BB077194
(S)-(-)-1,2-epoxydecane
Detail
Catalog: BB054100
Azetidine
Detail
Catalog: BB054600
3-glycidoxypropyltrimethoxysilane
Detail
Catalog: BB002009
Ethylenesulfate
Detail
Catalog: BB016437
2-amino-3-{pyrrolo[2,1-f][1,2,4]triazin-5-yl}propanenitrile
Detail
Catalog: BB014781
1,4-Benzodioxane-6-carbonitrile
Detail
Catalog: BB012200
8-(tetramethyl-1,3,2-dioxaborolan-2-yl)-4H-chromen-4-one
Detail
Catalog: BB016397
1-methyl-3-(1,3-thiazol-2-yl)-1H-pyrazole-5-carbaldehyde
Detail
Customer Support
If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?
Customer Centered
Global Delivery
Warehouses in multiple cities to ensure fast delivery
Quality Assurance
Strict process parameter control to ensure product quality
Large Stock
> 20,000 building blocks and intermediates from stock
Process Scale-up
Process scale-up from lab to industrial scale
Flexible Batch Size
Flexible batch size for diverse industrial demandsRelated Functional Groups
Other Building Blocks
Customers Also Viewed
Estra-1,3,5(10)-triene-3,17-diol,7-(9-bromononyl)-,17-acetate,(7a,17b)-
Copyright © 2025 BOC Sciences. All rights reserved.
Our Products
